Bidirectional on/off switch for controlled targeting of proteins to subcellular compartments

Journal of Controlled Release

Volumn 98, Issue 3, 2004, Pages 379-393

  Kanwal, C ^a   Mu, S ^a   Kern, S E ^a,b   Lim, C S ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

calreticulin; Controlled gene therapy; CRT; DBD; DMEM; DNA binding domain; Dulbecco's modified eagle's medium; EGFP; FBS; fetal bovine serum; LBD; ligand binding domain; Nucleus; Progesterone receptor; Protein switch; Subcellular trafficking

Indexed keywords

BINDING ENERGY; CONTROLLABILITY; CYTOLOGY; FLUORESCENCE; SIGNAL PROCESSING;

FUSION PROTEINS; NUCLEAR EXPORT SIGNAL (NES); NUCLEAR LOCALIZATION; PLASMID PRODUCTS;

PROTEINS;

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MIFEPRISTONE; PLASMID DNA; PROGESTERONE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL NUCLEUS MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DOSE CALCULATION; DRUG PROTEIN BINDING; FLUORESCENCE MICROSCOPY; GENE THERAPY; INTRACELLULAR SPACE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CLONING, MOLECULAR; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; GREEN FLUORESCENT PROTEINS; HORMONE ANTAGONISTS; LIGANDS; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MIFEPRISTONE; NUCLEAR LOCALIZATION SIGNALS; PLASMIDS; PROTEIN BINDING; RECEPTORS, PROGESTERONE; RECOMBINANT PROTEINS; SUBCELLULAR FRACTIONS;

EID: 4143062408     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.05.008     Document Type: Article

References (44)

1. Han S., Mahanoy R.I., Kim S.W. Water-soluble lipopolymer for gene delivery. Bioconjug. Chem. 12:2001;337-345
2. Hood J.K., Silver P.A. In or out? Regulating nuclear transport. Curr. Opin. Cell Biol. 11:1999;241-247
3. Lyman S.K., Guan T., Bednenko J., Wodrich H., Gerace L. Influence of cargo size on Ran and energy requirements for nuclear protein import. J. Cell Biol. 159:2002;55-67
4. Turpin P., Ossareh-Nazari B., Dargemont C. Nuclear transport and transcriptional regulation. FEBS Lett. 452:1999;82-86
5. Gorlich D., Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15:1999;607-660
6. Kalderon D., Roberts B.L., Richardson W.D., Smith A.E. A short amino acid sequence able to specify nuclear location. Cell. 39:1984;499-509
7. Efthymiadis A., Shao H., Hubner S., Jans D.A. Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence (NLS) in vivo and in vitro. A comparison with the SV40 large T-antigen NLS. J. Biol. Chem. 272:1997;22134-22139
8. Ylikomi T., Bocquel M.T., Berry M., Gronemeyer H., Chambon P. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J. 11:1992;3681-3694
9. Mattaj I.W., Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 67:1998;265-306
10. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1997;1051-1060
11. Macara I.G. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65:2001;570-594
12. Kanwal C., Li H., Lim C.S. Model system to study classical nuclear export signals. AAPS PharmSci. 4:2002
13. Walther R.F., Lamprecht C., Ridsdale A., Groulx I., Lee S., Lefebvre Y.A., Hache R.J. Nuclear export of the glucocorticoid receptor is accelerated by cell fusion-dependent release of calreticulin. J. Biol. Chem. 278:2003;37858-37864
14. Vegeto E., Allan G.F., Schrader W.T., Tsai M.J., McDonnell D.P., O'Malley B.W. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell. 69:1992;703-713
15. Siegel R.M., Chan F.K., Zacharias D.A., Swofford R., Holmes K.L., Tsien R.Y., Lenardo M.J. Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Sci. STKE. 2000:2000;L1
16. Tsien R.Y. The green fluorescent protein. Annu. Rev. Biochem. 67:1998;509-544
17. Lim C.S., Baumann C.T., Htun H., Xian W., Irie M., Smith C.L., Hager G.L. Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol. Endocrinol. 13:1999;366-375
18. Li H., Yan G., Kern S.E., Lim C.S. Correlation among agonist dose, rate of import, and transcriptional activity of liganded progesterone receptor B isoform in living cells. Pharm. Res. 20:2003;1574-1580
19. Htun H., Holth L.T., Walker D., Davie J.R., Hager G.L. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol. Biol. Cell. 10:1999;471-486
20. Schaufele F., Chang C.Y., Liu W., Baxter J.D., Nordeen S.K., Wan Y., Day R.N., McDonnell D.P. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor. Mol. Endocrinol. 14:2000;2024-2039
21. Lundberg M., Johansson M. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291:2002;367-371
22. Henderson B.R., Eleftheriou A. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 256:2000;213-224
23. Heger P., Lohmaier J., Schneider G., Schweimer K., Stauber R.H. Qualitative highly divergent nuclear export signals can regulate export by the competition for transport cofactors in vivo. Traffic. 2:2001;544-555
24. Wang Y., O'Malley B.W. Jr., Tsai S.Y., O'Malley B.W. A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. U. S. A. 91:1994;8180-8184
25. Philibert D., Moguilewsky M., Mary I., Lecaque D., Tournemine C., Secchi J., Deraedt R. The Antiprogestin Steroid RU486 and Human Fertility Control. 1985;Plenum, New York
26. Henderson D. Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Actions. 1987;Bailliere Tindall, London
27. Baim S.B., Labow M.A., Levine A.J., Shenk T. A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl beta-D-thiogalactopyranoside. Proc. Natl. Acad. Sci. U. S. A. 88:1991;5072-5076
28. Yarranton G.T. Inducible vectors for expression in mammalian cells. Curr. Opin. Biotechnol. 3:1992;506-511
29. Braselmann S., Graninger P., Busslinger M. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1657-1661
30. Shockett P.E., Schatz D.G. Diverse strategies for tetracycline-regulated inducible gene expression. Proc. Natl. Acad. Sci. U. S. A. 93:1996;5173-5176
31. Mizuguchi H., Hayakawa T. Characteristics of adenovirus-mediated tetracycline-controllable expression system. Biochim. Biophys. Acta. 1568:2001;21-29
32. Fender P., Jeanson L., Ivanov M.A., Colin P., Mallet J., Dedieu J.F., Latta-Mahieu M. Controlled transgene expression by E1-E4-defective adenovirus vectors harbouring a "tet-on" switch system. J. Gene Med. 4:2002;668-675
33. Zhao H.F., Boyd J., Jolicoeur N., Shen S.H. A coumermycin/novobiocin- regulated gene expression system. Hum. Gene Ther. 14:2003;1619-1629
34. Rivera V.M., Clackson T., Natesan S., Pollock R., Amara J.F., Keenan T., Magari S.R., Phillips T., Courage N.L., Cerasoli F. Jr., Holt D.A., Gilman M. A humanized system for pharmacologic control of gene expression. Nat. Med. 2:1996;1028-1032
35. No D., Yao T.P., Evans R.M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 93:1996;3346-3351
36. Palli S.R., Kapitskaya M.Z., Kumar M.B., Cress D.E. Improved ecdysone receptor-based inducible gene regulation system. Eur. J. Biochem. 270:2003;1308-1315
37. Suess B., Fink B., Berens C., Stentz R., Hillen W. A theophylline responsive riboswitch based on helix slipping controls gene expression in vivo. Nucleic Acids Res. 32:2004;1610-1614
38. Caddick M.X., Greenland A.J., Jepson I., Krause K.P., Qu N., Riddell K.V., Salter M.G., Schuch W., Sonnewald U., Tomsett A.B. An ethanol inducible gene switch for plants used to manipulate carbon metabolism. Nat. Biotechnol. 16:1998;177-180
39. Lee S.H., Hannick M. Molecular mechanisms that regulate transcription factor localization suggest new targets for drug development. Adv. Drug Deliv. Rev. 55:2003;717-731
40. Jans D.A., Chan C.K., Huebner S. Signals mediating nuclear targeting and their regulation: application in drug delivery. Med. Res. Rev. 18:1998;189-223
41. Bouchard P. Progesterone and the progesterone receptor. J. Reprod. Med. 44:1999;153-157
42. Lee E., Salic A., Kruger R., Heinrich R., Kirschner M.W. The roles of APC and axin derived from experimental and theoretical analysis of the Wnt pathway. PloS Biol. 1:2003;E10
43. Fabbro M., Henderson B.R. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282:2003;59-69
44. Keeshan K., Cotter T.G., McKenna S.L. Bcr-Abl upregulates cytosolic p21WAF-1/CIP-1 by a phosphoinositide-3-kinase (PI3K)-independent pathway. Br. J. Haematol. 123:2003;34-44